HRT in difficult circumstances: are there any absolute contraindications?

@article{Maclennan2011HRTID,
  title={HRT in difficult circumstances: are there any absolute contraindications?},
  author={Alastair H Maclennan},
  journal={Climacteric},
  year={2011},
  volume={14},
  pages={409 - 417}
}
Many traditional contraindications to hormone replacement therapy (HRT) are based on the theoretical potential for these hormones to worsen a disease process and are rarely based on supporting data. This review addresses the available data and lack of data that make the prescription of HRT difficult in a variety of common morbidities. In each circumstance, it is assumed that conservative evidence-based therapies have been tried and that menopausal symptoms remain debilitating and are reducing… 
Hormone Replacement Therapy: Would it be Possible to Replicate a Functional Ovary?
TLDR
The need, efficacy, and limitations of current HRT; the role of other ovarian hormones, and where they stand in comparison with ovary-in situ; and the preparation of an HRT model by regeneration of ovaries tissues through stem cells which can replicate a functional ovary are discussed.
Estrogen therapy in gynecological cancer survivors
  • F. Guidozzi
  • Medicine
    Climacteric : the journal of the International Menopause Society
  • 2013
TLDR
It is prudent not to offer estrogen therapy to survivors of endometrial stromal sarcoma and women with granulosa cell tumors of the ovaries, and estrogen therapy can be considered as a plausible therapeutic option in survivors who are debilitated by their menopausal symptoms.
Hormone replacement therapy for women previously treated for endometrial cancer.
TLDR
A large number of women diagnosed with endometrial cancer have early-stage disease, leading to a good prognosis after hysterectomy and removal of the ovaries, and there is a need for information about the risk and benefits of HRT, enabling women to make an informed decision, weighing the advantages and disadvantages of using HRT for their individual circumstances.
Efecto del consumo de soja en relación con los síntomas de la menopausia
TLDR
The objective of this review is to address some of the mechanisms of isoflavones and their role in the menopausal period, postulating that, as food supplements, they could be used as a complementary therapy for menopause symptoms.
Long-term benefits and risks of HRT (Section 11): Breast cancer
TLDR
World-wide hormone replacement therapy prescriptions fell significantly and have remained low due to concerns that the associated increased risk of breast cancer diagnosis is unacceptably high, despite the fact that the degree of risk of Breast cancer diagnosis was no greater than estimates from clinical studies published prior to WHI and the MWS or for that matter afterwards.
Does Hormone Replacement Therapy Impact the Prognosis in Endometrial Cancer Survivors? A Systematic Review
TLDR
This systematic review of studies published from January 1986 to January 2019 shows that HRT use had no negative effect on prognosis in EC survivors in tumour stages I and II.
Hormone Replacement Therapy Prescription After Premature Surgical Menopause.
TLDR
Patients with pelvic pain and Lynch syndrome were more likely to use HRT, whereas those with gynecologic or breast malignancy and BRCA gene mutations were less likely toUse HRT.
Menopausal hot flushes and night sweats: where are we now?
TLDR
Hot flushes are caused by changes in the central nervous system associated with estrogen withdrawal and are best treated with estrogen replacement therapy, and Objective monitoring of hot flushes indicates that placebo has little to no effect on their improvement.
The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China
TLDR
The hypothesis that postoperative HRT does not have a negative effect on the progression-free and overall survival of epithelial ovarian cancer patients is supported, however, a multicenter study is needed to support and extend the findings.
Molecular pathways: digoxin use and estrogen-sensitive cancers--risks and possible therapeutic implications.
  • R. Biggar
  • Medicine
    Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2012
TLDR
Significant increases in breast and uterus cancer incidences and a small but significant reduction in prostate cancer among men using digoxin are consistent with an estrogenic effect, and other estrogen-like drugs, particularly spironolactone, should be investigated for similar effects.
...
1
2
3
...

References

SHOWING 1-10 OF 69 REFERENCES
Is endometrial monitoring required with the use of long-term unopposed vaginal estrogen?
TLDR
There are inadequate clinical studies to inform us whether there is any clinically significant increased risk of endometrial cancer with the use of estrogen-alone vaginal preparations used daily or intermittently over many years, and it is argued that the answer should be ‘No’.
Is HRT justified for symptom management in women at higher risk of developing breast cancer?
  • L. Rippy, J. Marsden
  • Medicine
    Climacteric : the journal of the International Menopause Society
  • 2006
TLDR
Discussion of the current clinical uncertainty surrounding the use of HRT must be undertaken to ensure that women are adequately informed.
Menopause, hormone replacement and gynaecological cancers
TLDR
No study to date has found HRT to have a detrimental effect on survival in patients with early stage endometrial cancer, epithelial ovarian cancer, cervical cancer and vulval tumours, and HRT is only an absolute contraindication in low-grade endometricrial stromal sarcomas and is best avoided in granulosa cell ovarian tumours.
Hormone Therapy and the Risk of Breast Cancer in BRCA 1 Mutation Carriers
JNCI | Articles 1361 Approximately 3% of invasive breast cancers can be attributed to a mutation in BRCA1 or BRCA2 ( 1 ). Women who carry a BRCA1 mutation face a lifetime risk of breast cancer of 60%
Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.
TLDR
This randomized trial suggests that continuous combined estrogen plus progestin therapy may increase the risk of ovarian cancer while producing endometrial cancer rates similar to placebo, and provides additional support for caution in the use of continuous combined hormones.
Serotonergic Agents as an Alternative to Hormonal Therapy for the Treatment of Menopausal Vasomotor Symptoms
  • V. Stearns
  • Medicine
    Treatments in endocrinology
  • 2006
TLDR
Given the available data, the North American Menopause Society and the American College of Obstetricians and Gynecologists have recommended that women with moderate to severe, menopause-related hot flashes, with concerns or contraindications to estrogen-containing treatments, should consider prescription progestogens, venlafaxine, paroxetine, fluoxetines, or gabapentin.
Ovarian cancer patients and hormone replacement therapy: a systematic review.
TLDR
Until more evidence becomes available, it appears that HRT is acceptable for patients with ovarian cancer as part of supportive and symptomatic therapy.
Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
TLDR
Among postmenopausal women with a BRCA1 mutation, HT use was not associated with increased risk of breast cancer; indeed, in this population, it was associated with a decreased risk.
The Role of Hormone Replacement Therapy in the Risk for Breast Cancer and Total Mortality in Women with a Family History of Breast Cancer
TLDR
It is important to examine all-cause mortality when considering the risks and benefits of HRT use, especially among women with a family history of breast cancer, as part of the Iowa Women's Health Study.
Hormone Therapy and Ovarian Cancer
TLDR
It is concluded that HT increases the risk of ovarian cancer with slight effect on risk of different routes of administration, regimens, progestin types, length of use, and doses.
...
1
2
3
4
5
...